1. Home
  2. ASMB vs NEWT Comparison

ASMB vs NEWT Comparison

Compare ASMB & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$29.32

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

HOLD

Current Price

$12.79

Market Cap

395.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASMB
NEWT
Founded
2005
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
440.0M
395.5M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
ASMB
NEWT
Price
$29.32
$12.79
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$44.20
$15.33
AVG Volume (30 Days)
71.8K
225.4K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
5.97%
EPS Growth
91.78
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$235.63
$12.45
P/E Ratio
N/A
$5.99
Revenue Growth
N/A
N/A
52 Week Low
$9.82
$9.51
52 Week High
$39.71
$14.91

Technical Indicators

Market Signals
Indicator
ASMB
NEWT
Relative Strength Index (RSI) 53.18 65.49
Support Level $29.31 $12.64
Resistance Level $30.54 $14.91
Average True Range (ATR) 1.41 0.37
MACD 0.11 0.23
Stochastic Oscillator 70.11 98.37

Price Performance

Historical Comparison
ASMB
NEWT

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.

Share on Social Networks: